Le Lézard
Classified in: Health
Subjects: PDT, WOM, DEI

Solv Wellnesstm, Makers of Ellura®, Launches new Female Pelvic Health Prebiotic M?ge with a Proprietary Blend of the Most Clinically Studied Pre- and Probiotics


ATLANTA, Sept. 22, 2021 /PRNewswire/ -- Solv Wellness, LLC, formerly known as Trophikos, LLC, have released M?ge, a probiotic designed just for women. M?ge contains a proprietary blend of the most clinically studied pre- and probiotics that help restore balance to the female pelvic triangle: the gut, vagina, and urinary tract. This release comes as part of the company's rebranding to highlight their focus on women at midlife and beyond, and the often-stigmatized health issues they experience.  

NEW! Female pelvic health prebiotic M?ge has a proprietary blend of the most clinically studied pre- and probiotics.

Why a probiotic? Common pathogenic bacteria naturally exist in the body but are typically balanced by healthy bacteria, unless something occurs to offset that balance, like menopause. M?ge is uniquely formulated with the most clinically studied pre and probiotics to help restore that balance for women's pelvic health.  

"I regularly recommend probiotics targeted on female bladder and vaginal health," says Dr. Sophie Fletcher, Urologist, FPMRS, and Solv Wellness Medical Advisory Board Chair. "There are many options out there that just lack the right combination of ingredients, and I am thrilled to see the number of scientific studies that back each of the ingredients carefully selected for the M?ge blend." 

Available now at www.solvwellness.com, M?ge is the second product from Solv Wellness, demonstrating their commitment to bringing meaningful solutions to common but often stigmatized female health issues. 

"I have frequent conversations with other women my age, and it's beyond frustrating that women think they have to just 'deal with' certain changes that cause discomfort, pain and disruption to their lives and relationships," says Terri Wade, Co-Founder and CEO of Solv Wellness. "Women deserve better and should expect more for our second half of life, and that's exactly what Solv Wellness is here to help with." Solv Wellness is committed to bringing women solutions based in real science, using the highest quality ingredients, and that are recommended by doctors and proven to work 

About Solv Wellness 

Solv Wellness is joining the fight to help elevate the care of women at midlife and beyond by replacing stigmas with science for female pelvic health. For too long, women's needs at midlife and beyond have been underserved by the scientific and healthcare communities and, as a result, many women often dread much of what aging brings. Solv Wellness believes women should have meaningful solutions to many of the uncomfortable health conditions associated with aging and menopause, starting with pelvic health. 

About Ellura by Solv Wellness 

Backed by 20 clinical studies and 16 traditional herbal medicine approvals worldwide, Ellura is a clinically proven, daily supplement for non-antibiotic management of patients with recurrent urinary tract infections. Ellura's complex proprietary double extraction manufacturing process, extracting PAC only from the pure cranberry juice concentrate, results in the highest-shown levels of soluble A-type PAC to date and the highest level of bacterial Anti-Adhesion Activity compared to other available supplements on the market.  

For more information about Solv Wellness and product offerings visit solvwellness.com   

For clinical studies on potency, dosing, catheter use, and more, visit?ellurahcp.com

Contact Info-- 
Tamara Brown 
SVP, Marketing 
[email protected]
+1 (404) 618-4990 

PreforPro® and Bacillus subtilis DE111® are registered trademarks of Deerland Probiotics and Enzymes. 

SOURCE Solv Wellness


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: